First International Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,082
Closed -$295K 69
2023
Q3
$295K Sell
5,082
-1,069
-17% -$65.5K 0.11% 60
2023
Q2
$393K Buy
6,151
+118
+2% +$7.91K 0.13% 65
2023
Q1
$418K Buy
6,033
+491
+9% +$34.6K 0.14% 56
2022
Q4
$399K Buy
5,542
+57
+1% +$4.3K 0.14% 62
2022
Q3
$390K Buy
+5,485
New +$398K 0.15% 60

Other funds holding BMY

First International Bank & Trust's BMY Position: Q4 2023 in Review

First International Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 5,082 shares — an estimated $295K sold.

First International Bank & Trust first reported a position in BMY in Q3 2022 and held it in 5 quarters. The position peaked at $418K in Q1 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • First International Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • First International Bank & Trust sold 5,082 Bristol-Myers Squibb shares in Q4 2023, an estimated $295K.
  • First International Bank & Trust first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 5 quarters.
  • First International Bank & Trust's Bristol-Myers Squibb position peaked at $418K in Q1 2023.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on First International Bank & Trust's 13F filing for Q4 2023, filed 9 Jan 2024.